Galidesivir

Galidesivir is an antiviral drug that is currently under investigation for its potential to treat a variety of viral diseases. It is a broad-spectrum antiviral that has shown efficacy against several viruses in preclinical studies.

Mechanism of Action

Galidesivir works by inhibiting the RNA polymerase enzyme, which is essential for the replication of many viruses. By blocking this enzyme, galidesivir can prevent the virus from replicating and spreading in the body.

Clinical Trials

Galidesivir has been tested in several clinical trials for its potential to treat diseases caused by viruses such as Zika, Ebola, and Yellow Fever. The drug has shown promising results in these trials, but further research is needed to confirm its efficacy and safety.

Potential Uses

In addition to its potential use in treating diseases caused by Zika, Ebola, and Yellow Fever viruses, galidesivir may also have potential in treating other viral diseases. Its broad-spectrum antiviral activity suggests that it could be effective against a wide range of viruses.

Safety and Side Effects

As with any drug, galidesivir may cause side effects. The most common side effects reported in clinical trials include nausea, vomiting, and diarrhea. More serious side effects may also occur, but these are rare.

See Also

• Antiviral drug
• Clinical trial
• RNA polymerase
• Zika virus
• Ebola virus
• Yellow Fever virus

Galidesivir Resources
Latest articles Most recent articles Ongoing trials	Wikipedia